Related Experiment Videos
Cutaneous melanoma: prognostic factors.
Jade Homsi1, Mohammed Kashani-Sabet, Jane L Messina
1Cutaneous Oncology Division, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Cancer Control : Journal of the Moffitt Cancer Center
|November 1, 2005
Summary
Understanding prognostic factors like lesion thickness and lymph node involvement is key for cutaneous melanoma survival. Newer insights are improving treatment strategies for localized and metastatic melanoma.
Area of Science:
- Dermatology
- Oncology
- Pathology
Background:
- Evolving understanding of prognostic factors in cutaneous melanoma.
- Newer methods and population-based analyses provide enhanced prognostic information.
- Insights into melanoma prognosis have advanced significantly.
Purpose of the Study:
- To review current data on prognostic factors in cutaneous melanoma.
- To categorize factors for localized primary and metastatic melanoma.
- To assess the evidence and clinical applicability of each prognostic factor.
Main Methods:
- Comprehensive review of current scientific data on prognostic factors.
- Categorization of prognostic factors based on melanoma stage (localized vs. metastatic).
- Evaluation of the evidential support and clinical utility for each factor.
Main Results:
- Key predictors for localized melanoma: thickness, ulceration, lymph node status, age, sex, location, satellites.
- Emerging factors for localized melanoma: vascularity, invasion, mitotic rate, regression, TILs.
- Primary predictors for metastatic melanoma: metastasis site, elevated LDH.
Conclusions:
- Improved understanding of prognostic factors aids oncologists in tailoring melanoma treatment.
- Prognostic factors are often interrelated, requiring a holistic view.
- Future research into molecular genetic factors is expected to further refine melanoma prognosis.